CN102860982A - Tilianin microemulsion composition - Google Patents
Tilianin microemulsion composition Download PDFInfo
- Publication number
- CN102860982A CN102860982A CN2012103851340A CN201210385134A CN102860982A CN 102860982 A CN102860982 A CN 102860982A CN 2012103851340 A CN2012103851340 A CN 2012103851340A CN 201210385134 A CN201210385134 A CN 201210385134A CN 102860982 A CN102860982 A CN 102860982A
- Authority
- CN
- China
- Prior art keywords
- parts
- tiliannin
- water
- microemulsion
- emulsifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses a microemulsion composition containing tilianin. The microemulsion composition comprises tilianin, an emulsifier, a co-emulsifier, oil and water. The microemulsion composition can greatly enhance the solubility of the tlianin.
Description
Technical field
The present invention relates to a kind of tiliannin micro-emulsion composition that can significantly increase the tiliannin dissolubility.
Background technology
Tiliannin is an important flavonoid glycoside compound that extracts from the labiate Herba Dracocephali, has the biological activitys such as atherosclerosis, resisting hypertension, protection cardiac muscle.Tiliannin belongs to weak acid class medicine, is insoluble in water, is soluble in the organic solvents such as acetonitrile, dimethyl sulfoxide, methanol, chloroform, ethyl acetate.The character of the water-soluble difference of tiliannin has limited the effective exploitation utilization of its preparation.
The Chinese patent notification number is the preparation method that CN10178345A discloses tiliannin, and still, the deficiency of the method is, not according to the water-fast character of tiliannin, for disclosed tiliannin provides a kind of method that increases dissolubility for satisfying the preparation needs.
Summary of the invention
The object of the present invention is to provide a kind of micro-emulsion composition that the tiliannin dissolubility can significantly be provided.
The object of the present invention is achieved like this:
The tiliannin micro-emulsion composition is comprised of tiliannin and adjuvant.
The adjuvant of tiliannin micro-emulsion composition is comprised of emulsifying agent, co-emulsifier, oil phase and water.Emulsifying agent in the microemulsion adjuvant comprises at least a of polyoxyethylene hydrogenated Oleum Ricini, polyoxyethylene castor oil, lecithin, fabaceous lecithin, tween 80; Co-emulsifier comprises at least a of PEG-4000, propylene glycol, ethanol, glycerol; Oil phase comprises at least a of ethyl oleate, oleic acid, Miglyol 812, isopropyl palmitate, isopropyl myristate; Microemulsion adjuvant weight portion consists of 1~25 part of emulsifying agent, 2~50 parts of co-emulsifier, and 5~20 parts of oil phases, water are 10-80 part.
The tiliannin weight portion consists of 0.05~1 part in the tiliannin microemulsion.
The present invention compared with prior art, the tiliannin micro-emulsion composition is to adopt the pharmaceutics means, significantly increase the method for tiliannin solubility method take microemulsion as carrier, the dissolubility of tiliannin in microemulsion is 1300~1500 times in the water, the method does not change the physicochemical properties of tiliannin, have the simple characteristics of preparation method, for the tiliannin preparation research is laid a good foundation.
The specific embodiment
Embodiment 1
Tiliannin: 0.2 part, polyoxyethylene hydrogenated Oleum Ricini: 5 parts, PEG-4000: 10 parts, isopropyl myristate: 10 parts, water: 30 parts
Embodiment 2
Tiliannin: 0.2 part, lecithin: 9 parts, ethanol: 9 parts, ethyl oleate: 10 parts, water: 20 parts
Embodiment 3
Tiliannin: 0.4 part, tween 80: 10 parts, propylene glycol: 5 parts, ethyl oleate: 10 parts, water: 10 parts
Embodiment 4
Tiliannin: 0.5 part, tween 80: 20 parts, ethanol: 10 parts, oleic acid: 10 parts, water: 60 parts
Embodiment 5
Tiliannin: 0.6 part, polyethylene glycol hydrogenated alkene Oleum Ricini: 10 parts, PEG-4000: 20 parts, ethyl oleate: 15 parts, water: 50 parts
Embodiment 6
Tiliannin: 0.2 part, polyoxyethylene castor oil: 20 parts, glycerol: 10 parts, isopropyl myristate: 20 parts, water: 30 parts
Embodiment 7
Tiliannin: 0.1 part, polyoxyethylene hydrogenated Oleum Ricini: 20 parts, ethanol: 20 parts, isopropyl palmitate: 15 parts, water: 40 parts
Embodiment 8
Tiliannin: 0.2 part, polyethylene glycol hydrogenated alkene Oleum Ricini: 20 parts, ethanol: 20 parts, Miglyol 812: 10 parts, water: 55 parts
Embodiment 9
Tiliannin: 0.4 part, 10 parts of fabaceous lecithins, 7.5 parts of glycerol, oleic acid: 15 parts, 15 parts of waters
Embodiment 10
Tiliannin: 0.09 part, 25 parts of tween 80s, glycerol: 15 parts, oleic acid: 18 parts, water: 80 parts
Embodiment 11
Tiliannin: 1 part, polyoxyethylene hydrogenated Oleum Ricini: 20 parts, propylene glycol: 30 parts, isopropyl palmitate: 20 parts, water: 65 parts
Embodiment 12
Tiliannin: 0.05 part, 20 parts in lecithin, propylene glycol: 40 parts, ethyl oleate: 10 parts, water: 55 parts
Embodiment 13
Tiliannin: 0.7 part, tween 80: 20 parts, ethanol: 20 parts, isopropyl myristate: 18 parts, water: 60 parts
Embodiment 14
Tiliannin: 0.8 part, polyoxyethylene hydrogenated Oleum Ricini: 20 parts, propylene glycol: 35 parts, ethyl oleate: 10 parts, water: 50 parts
Embodiment 15
Tiliannin: 0.9 part, polyoxyethylene castor oil: 20 parts, PEG-4000: 20 parts, oleic acid: 10 parts, water: 70 parts.
Claims (3)
1. micro-emulsion composition that contains tiliannin, it is characterized in that, this microemulsion is comprised of tiliannin and adjuvant, adjuvant is comprised of emulsifying agent, co-emulsifier, oil phase, water, and emulsifying agent is selected from least a of polyoxyethylene hydrogenated Oleum Ricini, polyoxyethylene castor oil, lecithin, fabaceous lecithin, tween 80; Co-emulsifier is selected from least a of PEG-4000, propylene glycol, ethanol, glycerol; Oil phase be selected from ethyl oleate, oleic acid, Miglyol 812, isopropyl palmitate, isopropyl myristate, at least a.
2. the micro-emulsion composition that contains tiliannin according to claim 1 is characterized in that the tiliannin weight portion consists of 0.05~1 part in the tiliannin microemulsion.
3. the micro-emulsion composition of tiliannin according to claim 1 is characterized in that described microemulsion adjuvant weight portion consists of 1~25 part of emulsifying agent, 2~50 parts of co-emulsifier, and 5~20 parts of oil phases, water are 10-80 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210385134.0A CN102860982B (en) | 2012-10-09 | 2012-10-09 | Tilianin microemulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210385134.0A CN102860982B (en) | 2012-10-09 | 2012-10-09 | Tilianin microemulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102860982A true CN102860982A (en) | 2013-01-09 |
CN102860982B CN102860982B (en) | 2014-08-20 |
Family
ID=47440302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210385134.0A Expired - Fee Related CN102860982B (en) | 2012-10-09 | 2012-10-09 | Tilianin microemulsion composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102860982B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961316A (en) * | 2014-05-13 | 2014-08-06 | 浙江凯胜科技有限公司 | Micro-emulsion containing enramycin and preparation method thereof |
CN107115321A (en) * | 2017-04-16 | 2017-09-01 | 新疆维吾尔自治区药物研究所 | Creeping thistle glycosides solid lipid nanoparticle and preparation method thereof |
CN111603447A (en) * | 2020-06-17 | 2020-09-01 | 新疆维吾尔自治区药物研究所 | Tilianin solid dispersion and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101781345A (en) * | 2010-02-10 | 2010-07-21 | 石河子大学医学院第一附属医院 | Method for preparing tilianin |
CN102106818A (en) * | 2010-12-14 | 2011-06-29 | 石河子大学医学院第一附属医院 | Isoliquiritigenin micro-emulsion composition |
-
2012
- 2012-10-09 CN CN201210385134.0A patent/CN102860982B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101781345A (en) * | 2010-02-10 | 2010-07-21 | 石河子大学医学院第一附属医院 | Method for preparing tilianin |
CN102106818A (en) * | 2010-12-14 | 2011-06-29 | 石河子大学医学院第一附属医院 | Isoliquiritigenin micro-emulsion composition |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961316A (en) * | 2014-05-13 | 2014-08-06 | 浙江凯胜科技有限公司 | Micro-emulsion containing enramycin and preparation method thereof |
CN103961316B (en) * | 2014-05-13 | 2020-01-07 | 浙江工商大学 | Microemulsion containing enramycin and preparation method thereof |
CN107115321A (en) * | 2017-04-16 | 2017-09-01 | 新疆维吾尔自治区药物研究所 | Creeping thistle glycosides solid lipid nanoparticle and preparation method thereof |
CN111603447A (en) * | 2020-06-17 | 2020-09-01 | 新疆维吾尔自治区药物研究所 | Tilianin solid dispersion and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102860982B (en) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102106818B (en) | Isoliquiritigenin micro-emulsion composition | |
Ok et al. | Optimization of extraction conditions for the 6-shogaol-rich extract from ginger (Zingiber officinale Roscoe) | |
CN102860982B (en) | Tilianin microemulsion composition | |
Aggarwal et al. | Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application | |
Chen et al. | Characterization, pharmacokinetics and tissue distribution of chlorogenic acid-loaded self-microemulsifying drug delivery system | |
CA2864118A1 (en) | Formulations of bendamustine | |
WO2011144745A3 (en) | Improved liposomal formulations of lipophilic compounds | |
KR20170138178A (en) | Composition of High Functional Cometics Using High Content Solubilization of Natural Caffeine derived Green Tea | |
CN103285401A (en) | Composition capable of improving solubility and bioavailability of insoluble medicament | |
WO2008081831A1 (en) | External preparation for skin and skin-whitening agent | |
CN101474151A (en) | Alkannin microemulsion composition | |
NZ612185A (en) | Topical combination formulations of macrocyclic lactones with synthetic pyrethroids | |
NZ705751A (en) | Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using ageratum spp. | |
WO2014178789A9 (en) | Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients | |
CN101099733B (en) | Taxol freezing-dried emulsion for injection and preparation method thereof | |
Mao et al. | Ethosomes as delivery system for transdermal administration of vinpocetine | |
WO2006034147A3 (en) | Compositions and methods for the preparation and administration of poorly water soluble drugs | |
Wen et al. | Convergence analysis of mean shift algorithm. | |
Bachhav et al. | Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems | |
CN102273470B (en) | Daucosterol plant miticide and purpose thereof | |
Roni et al. | Comparative study of ibuprofen solubility in synthetic and natural lipid vehicles | |
KR20170138175A (en) | Composition of Hair Loss Prevension Cosmetics Using Solubilization Technic of Poorly Water Soluble of Natural Caffeine derived Coffee | |
CN110859804A (en) | Radix aucklandiae extract microemulsion and preparation method and application thereof | |
CN104739807B (en) | A kind of total toadpoison lactone nano-micelle preparations and preparation method thereof | |
WO2010136952A3 (en) | Self-microemulsifying mitotane composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140820 Termination date: 20171009 |
|
CF01 | Termination of patent right due to non-payment of annual fee |